Avoro Capital Advisors — 2017 Investments

5 investments dated 2017 · listed companies and verified rows first · show all

Viking Therapeuticsvikingtherapeutics.com inNASDAQ: VKTXJun 2017

Viking Therapeutics is a clinical-stage biopharmaceutical company developing therapies in areas such as metabolic and endocrine disorders.

BiotechHealthtechLongevitySan Diego, US

Brian Lian(President, CEO & Director (Founder))inMichael Morneau(Chief Financial Officer)Dr. Lian(President & Chief Executive Officer, Director)Stephen W. Webster(Director)Matthew W. Foehr(Director)Brian Lian, Ph.D.(President and Chief Executive Officer; founder of Viking Therapeutics)

Co-investorsLigand Pharmaceuticals

Fennec Pharmaceuticalsfennecpharma.com in 𝕏Jun 2017

Fennec Pharmaceuticals develops treatments for cisplatin-induced hearing loss, a side effect of cancer chemotherapy.

BiotechHealthtechMedical DevicesResearch Triangle Park, US

Krysia Lynes(Executive Officer)Rostislav Raykov(Executive Officer, Director)

BoardAdrian Haigh(Director)Steven Skolsky(Director)Chris Rallis(Director)Khalid Islam(Director)

Krystal Biotechkrystalbio.com in 𝕏Aug 2017

Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions.

BiotechHealthtechMedical DevicesPittsburgh, US

Suma Krishnan(President, Research & Development)inKrish Krishnan(Chairman & CEO)inDoug Norby(Director)Dino Rossi(Director)

BoardDan Janney(Director)

Co-investorsFrazier Life Sciences Alta Partners

PMV Pharmapmvpharma.comFeb 2017

PMV Pharma is a precision oncology company developing therapies that selectively target mutant p53 to treat cancers whose tumors carry p53 gene mutations.

BiotechHealthtechLongevityCranbury, US

David H. Mack, Ph.D.(Founder)inDavid Mack(Executive Officer, Director)Arnold Levine(Co-Founder & Member, Scientific Advisory Board)David H. Mack(Co-Founder, President & CEO)Thomas Shenk(Co-Founder)Deepika Jalota(Chief Development Officer)

Co-investorsNextech Invest OUP (Osage University Partners)RA Capital Viking Global Wellington Management OrbiMed

Trillium Therapeuticstrilliumtherapeutics.comDec 2017

BiotechMississauga

Niclas Stiernholm(Executive Officer, Director)Robert Uger(Executive Officer)Calvin Stiller(Director)James Parsons(Executive Officer)Helen Tayton-Martin(Director)Robert Kirkman(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.